Who owns psychedelics: patents and state therapeutic access laws

In anticipation of the vote this coming Tuesday on Oregon Measure 109, attorney Graham Pechenik and I discussed whether patent law gives the right to “own” a psychedelic molecule, what Compass Pathways’ patent means, and how patent law might interact with a state law legalizing manufacture and supervised therapeutic use of psychedelic substances.

(To skip over the discussion of how patents work generally and listen to discussion of the Oregon initiative, go to 18:11.)

One thought on “Who owns psychedelics: patents and state therapeutic access laws

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s